{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "OtherID": [], "GeneralNote": [], "KeywordList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "PMID": "39217427", "DateRevised": {"Year": "2024", "Month": "09", "Day": "01"}, "Article": {"ELocationID": ["10.4103/mgr.MEDGASRES-D-23-00013"], "ArticleDate": [{"Year": "2024", "Month": "08", "Day": "31"}], "Language": ["eng"], "Journal": {"ISSN": "2045-9912", "JournalIssue": {"PubDate": {"Year": "2024", "Month": "Aug", "Day": "31"}}, "Title": "Medical gas research", "ISOAbbreviation": "Med Gas Res"}, "ArticleTitle": "Oxygen-ozone therapy for myocardial ischemic stroke and cardiovascular disorders.", "Abstract": {"AbstractText": ["Cardiovascular diseases (CVDs) represent a major concern for human health worldwide. Emergencies in this field include wide repertories of studies dealing primarily with CVD prevention. In addition to dietary habits and lifestyles, medical knowledge is fully needed to improve public educational programs toward cardiovascular risk factors and to enrich the endowment of pharmaceutical options and therapies to address CVDs, particularly for ischemic damage due to an impairment in the endothelial-myocardial relationship. Because ozone is a stimulator of the endothelial nitric oxide synthase/nitric oxide pathway, ozone therapy has been widely demonstrated to have the ability to counteract endothelial-cardiac disorders, providing a novel straightforward opportunity to reduce the impact of CVDs, including atrial fibrillation. In this review, we attempt to establish a state-of-the-art method for the use of ozone in CVD, suggesting that future remarks be addressed to provide fundamental insights into this issue. The purpose of this study was to highlight the role of ozone in the adjunctive medical treatment of cardiovascular pathologies such as acute myocardial infarction due to ischemic disorders."], "CopyrightInformation": "Copyright \u00a9 2025 Copyright: \u00a9 2025 Medical Gas Research."}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "High School Master of Oxygen Ozone Therapy, University of Pavia, Pavia, Italy."}, {"Identifier": [], "Affiliation": "Italian Scientific Society of Oxygen-Ozone Therapy (SIOOT), Gorle, Italy."}], "Identifier": [], "LastName": "Pandolfi", "ForeName": "Sergio", "Initials": "S"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy."}], "Identifier": ["0000-0003-1789-8307"], "LastName": "Chirumbolo", "ForeName": "Salvatore", "Initials": "S"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "High School Master of Oxygen Ozone Therapy, University of Pavia, Pavia, Italy."}, {"Identifier": [], "Affiliation": "Italian Scientific Society of Oxygen-Ozone Therapy (SIOOT), Gorle, Italy."}], "Identifier": [], "LastName": "Franzini", "ForeName": "Marianno", "Initials": "M"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "Tirelli Medical Group, Pordenone, Italy."}], "Identifier": [], "LastName": "Tirelli", "ForeName": "Umberto", "Initials": "U"}, {"AffiliationInfo": [{"Identifier": [], "Affiliation": "High School Master of Oxygen Ozone Therapy, University of Pavia, Pavia, Italy."}, {"Identifier": [], "Affiliation": "Italian Scientific Society of Oxygen-Ozone Therapy (SIOOT), Gorle, Italy."}], "Identifier": [], "LastName": "Valdenassi", "ForeName": "Luigi", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Australia", "MedlineTA": "Med Gas Res", "NlmUniqueID": "101564536", "ISSNLinking": "2045-9912"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Townsend N, Kazakiewicz D, Lucy Wright F, et al. Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol. 2022;19:133-143."}, {"Citation": "GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736-1788."}, {"Citation": "Panico S, Mattiello A. Epidemiology of cardiovascular diseases in women in Europe. Nutr Metab Cardiovasc Dis. 2010;20:379-385."}, {"Citation": "Saglietto A, Manfredi R, Elia E, et al. Cardiovascular disease burden: Italian and global perspectives. Minerva Cardiol Angiol. 2021;69:231-240."}, {"Citation": "Jensen RV, Hjortbak MV, B\u2298tker HE. Ischemic heart disease: an update. Semin Nucl Med. 2020;50:195-207."}, {"Citation": "Khan MA, Hashim MJ, Mustafa H, et al. Global epidemiology of ischemic heart disease: results from the Global Burden of Disease Study. Cureus. 2020;12:e9349."}, {"Citation": "Boden WE, Stone PH. Lessons learned from the ISCHEMIA trial for the management of patients with stable ischemic heart disease. Annu Rev Med. 2023;74:189-198."}, {"Citation": "Severino P, D'Amato A, Pucci M, et al. Ischemic heart disease pathophysiology paradigms overview: from plaque activation to microvascular dysfunction. Int J Mol Sci. 2020;21:8118."}, {"Citation": "Shao C, Wang J, Tian J, Tang YD. Coronary artery disease: from mechanism to clinical practice. Adv Exp Med Biol. 2020;1177:1-36."}, {"Citation": "Bassareo PP, O'Brien ST, Dunne E, et al. Should we be screening for ischaemic heart disease earlier in childhood? Children (Basel). 2022;9:982."}, {"Citation": "Meyer JF, Larsen SB, Blond K, Damsgaard CT, Bjerregaard LG, Baker JL. Associations between body mass index and height during childhood and adolescence and the risk of coronary heart disease in adulthood: A systematic review and meta-analysis. Obes Rev. 2021;22:e13276."}, {"Citation": "Alatorre CI, Hoogwerf BJ, Deeg MA, et al. Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly- diagnosed type 2 diabetes and early glycemic control. Curr Med Res Opin. 2018;34:337-343."}, {"Citation": "Owlia M, Dodson JA, King JB, et al. Angina severity, mortality, and healthcare utilization among veterans with stable angina. J Am Heart Assoc. 2019;8:e012811."}, {"Citation": "Prati F, Gurguglione G, Biccire F, et al. Sudden cardiac death in ischaemic heart disease: coronary thrombosis or myocardial fibrosis? Eur Heart J Suppl. 2023;25:B136-B139."}, {"Citation": "Scheitz JF, Sposato LA, Schulz-Menger J, Nolte CH, Backs J, Endres M. Stroke-heart syndrome: recent advances and challenges. J Am Heart Assoc. 2022;11:e026528."}, {"Citation": "Fr\u0105k W, Wojtasi\u0144ska A, Lisi\u0144ska W, M\u0142ynarska E, Franczyk B, Rysz J. Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease. Biomedicines. 2022;10:1938."}, {"Citation": "Fedele F, Severino P, Bruno N, et al. Role of ion channels in coronary microcirculation: a review of the literature. Future Cardiol. 2013;9:897-905."}, {"Citation": "Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72:2231-2264."}, {"Citation": "Crea F, Montone RA. Pathophysiology of coronary microvascular dysfunction. Vascul Pharmacol. 2023;153:107239."}, {"Citation": "Lerman A, Holmes DR, Herrmann J, Gersh BJ. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur Heart J. 2007;28:788-797."}, {"Citation": "Berry C, Duncker DJ. Coronary microvascular disease: the next frontier for cardiovascular research. Cardiovasc Res. 2020;116:737-740."}, {"Citation": "Urbieta Caceres VH, Lin J, Zhu XY, et al. Early experimental hypertension preserves the myocardial microvasculature but aggravates cardiac injury distal to chronic coronary artery obstruction. Am J Physiol Heart Circ Physiol. 2011;300:H693-701."}, {"Citation": "Sorop O, Merkus D, de Beer VJ, et al. Functional and structural adaptations of coronary microvessels distal to a chronic coronary artery stenosis. Circ Res. 2008;102:795-803."}, {"Citation": "Duncker DJ, Koller A, Merkus D, Canty JM Jr. Regulation of coronary blood flow in health and ischemic heart disease. Prog Cardiovasc Dis. 2015;57:409-422."}, {"Citation": "Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143:e254-e743."}, {"Citation": "Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145:e153-e639."}, {"Citation": "Oikonomou E, Siasos G, Tsigkou V, et al. Coronary artery disease and endothelial dysfunction: novel diagnostic and therapeutic approaches. Curr Med Chem. 2020;27:1052-1080."}, {"Citation": "Medina-Leyte DJ, Zepeda-Garc\u00eda O, Dom\u00ednguez-P\u00e9rez M, Gonz\u00e1lez- Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci. 2021;22:3850."}, {"Citation": "Violi F, Soliman EZ, Pignatelli P, Pastori D. Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. J Am Heart Assoc. 2016;5:e003347."}, {"Citation": "Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375."}, {"Citation": "Murphy NF, Simpson CR, Jhund PS, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart. 2007;93:606-612."}, {"Citation": "Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104:1534-1539."}, {"Citation": "Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114:119-125."}, {"Citation": "Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22:983-988."}, {"Citation": "Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155:469-473."}, {"Citation": "Kornej J, B\u00f6rschel CS, Benjamin EJ, Schnabel RB. Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights. Circ Res. 2020;127:4-20."}, {"Citation": "Leowattana W, Leowattana T, Leowattana P. Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation. World J Clin Cases. 2022;10:9588-9601."}, {"Citation": "El-Shetry M, Mahfouz R, Frere AF, Abdeldayem M. The interplay between atrial fibrillation and acute myocardial infarction. Br J Hosp Med (Lond). 2021;82:1-9."}, {"Citation": "Pignatelli P, Pastori D, Carnevale R, et al. Serum NOX2 and urinary isoprostanes predict vascular events in patients with atrial fibrillation. Thromb Haemost. 2015;113:617-624."}, {"Citation": "Li H, Sun K, Zhao R, et al. Inflammatory biomarkers of coronary heart disease. Front Biosci (Schol Ed). 2018;10:185-196."}, {"Citation": "Bockus L, Kim F. Coronary endothelial dysfunction: from pathogenesis to clinical implications. Open Heart. 2022;9:e002200."}, {"Citation": "Allbritton-King JD, Garc\u00eda-Carde\u00f1a G. Endothelial cell dysfunction in cardiac disease: driver or consequence? Front Cell Dev Biol. 2023;11:1278166."}, {"Citation": "Shimabukuro M. L-Arginine, Nitric Oxide, and Endothelial Dysfunction Underlying Atherosclerotic Cardiovascular Disease (ASCVD). J Atheroscler Thromb. 2023;30:1311-1312."}, {"Citation": "Herrera-Zelada N, Zuniga-Cuevas U, Ramirez-Reyes A, Lavandero S, Riquelme JA. Targeting the endothelium to achieve cardioprotection. Front Pharmacol. 2021;12:636134."}, {"Citation": "Shen X, Tan Z, Zhong X, et al. Endocardial endothelium is a key determinant of force-frequency relationship in rat ventricular myocardium. J Appl Physiol (1985). 2013;115:383-393."}, {"Citation": "Yang Q, He GW, Underwood MJ, Yu CM. Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection. Am J Transl Res. 2016;8:765-777."}, {"Citation": "Devan AE, Umpierre D, Harrison ML, et al. Endothelial ischemia- reperfusion injury in humans: association with age and habitual exercise. Am J Physiol Heart Circ Physiol. 2011;300:H813-819."}, {"Citation": "Zhu MX, Ma XF, Niu X, Fan GB, Li Y. Mitochondrial unfolded protein response in ischemia-reperfusion injury. Brain Res. 2022;1797:148116."}, {"Citation": "Ji H, Wang J, Muid D, Song W, Jiang Y, Zhou H. FUNDC1 activates the mitochondrial unfolded protein response to preserve mitochondrial quality control in cardiac ischemia/reperfusion injury. Cell Signal. 2022;92:110249."}, {"Citation": "Chen J, Henderson GI, Freeman GL. Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J Mol Cell Cardiol. 2001;33:1919-1927."}, {"Citation": "Wang J, Toan S, Zhou H. New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis. 2020;23:299-314."}, {"Citation": "Cong L, Bai Y, Guo Z. The crosstalk among autophagy, apoptosis, and pyroptosis in cardiovascular disease. Front Cardiovasc Med. 2022;9:997469."}, {"Citation": "Zhou H, Toan S. Pathological roles of mitochondrial oxidative stress and mitochondrial dynamics in cardiac microvascular ischemia/reperfusion injury. Biomolecules. 2020;10:85."}, {"Citation": "Weerateerangkul P, Chattipakorn S, Chattipakorn N. Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury. Med Sci Monit. 2011;17:RA44-52."}, {"Citation": "Navati MS, Lucas A, Liong C, et al. Reducing ischemia/reperfusion injury by the targeted delivery of nitric oxide from magnetic-field-induced localization of S-nitrosothiol-coated paramagnetic nanoparticles. ACS Appl Bio Mater. 2019;2:2907-2919."}, {"Citation": "Landmesser U, Engberding N, Bahlmann FH, et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation. 2004;110:1933-1939."}, {"Citation": "Ajamieh HH, Men\u00e9ndez S, Mart\u00ednez-S\u00e0nchez G, et al. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int. 2004;24:55-62."}, {"Citation": "Elvis AM, Ekta JS. Ozone therapy: A clinical review. J Nat Sci Biol Med. 2011;2:66-70."}, {"Citation": "Di Filippo C, Cervone C, Rossi C, et al. Antiarrhythmic effect of acute oxygen-ozone administration to rats. Eur J Pharmacol. 2010;629:89-95."}, {"Citation": "Di Filippo C, Luongo M, Marfella R, et al. Oxygen/ozone protects the heart from acute myocardial infarction through local increase of eNOS activity and endothelial progenitor cells recruitment. Naunyn Schmiedebergs Arch Pharmacol. 2010;382:287-291."}, {"Citation": "Franzini M, Valdenassi L, Pandolfi S, et al. The biological activity of medical ozone in the hormetic range and the role of full expertise professionals. Front Public Health. 2022;10:979076."}, {"Citation": "Bocci V, Travagli V, Zanardi I. May oxygen-ozone therapy improves cardiovascular disorders? Cardiovasc Hematol Disord Drug Targets. 2009;9:78-85."}, {"Citation": "Mart\u00ednez-S\u00e0nchez G, Delgado-Roche L, D\u00edaz-Batista A, P\u00e9rez-Davison G, Re L. Effects of ozone therapy on haemostatic and oxidative stress index in coronary artery disease. Eur J Pharmacol. 2012;691:156-162."}, {"Citation": "Le\u00f2n Fern\u00e1ndez OS, Ajamieh HH, Berlanga J, et al. Ozone oxidative preconditioning is mediated by A1 adenosine receptors in a rat model of liver ischemia/ reperfusion. Transpl Int. 2008;21:39-48."}, {"Citation": "Bocci V, Valacchi G, Rossi R, et al. Studies on the biological effects of ozone: 9. Effects of ozone on human platelets. Platelets. 1999;10:110-116."}, {"Citation": "Tylicki L, Lizakowski S, Biedunkiewicz B, et al. Platelet function unaffected by ozonated autohaemotherapy in chronically haemodialysed patients. Blood Coagul Fibrinolysis. 2004;15:619-622."}, {"Citation": "Valacchi G, Bocci V. Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells. Mediators Inflamm. 2000;9:271-276."}, {"Citation": "Giunta R, Coppola A, Luongo C, et al. Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann Hematol. 2001;80:745-748."}, {"Citation": "Turczy\u0144ski B, Sroczy\u0144ski J, Antoszewski Z, et al. Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical components in patients with diabetes type II and ischemia of the lower extremities. Pol Tyg Lek. 1991;46:708-710."}, {"Citation": "Verrazzo G, Coppola L, Luongo C, et al. Hyperbaric oxygen, oxygen-ozone therapy, and rheologic parameters of blood in patients with peripheral occlusive arterial disease. Undersea Hyperb Med. 1995;22:17-22."}, {"Citation": "Buyuklu M, Kandemir FM, Set T, et al. Beneficial effects of ozone therapy on oxidative stress, cardiac functions and clinical findings in patients with heart failure reduced ejection fraction. Cardiovasc Toxicol. 2017;17:426-433."}, {"Citation": "Pandolfi S, Zammitti A, Franzini M, et al. Effects of oxygen ozone therapy on cardiac function in a patient with a prior myocardial infarction. Ozone Ther. 2017;2:6745."}, {"Citation": "Cecilio Cespedes-Suarez J, Conde-Perez P, Calunga-Fernandez JL, et al. Study of Left Ventricle Ejection Fraction and Natriuretic Peptides in patients with heart failure treated with systemic medical ozone J Ozone Ther. 2021;5:69-78."}, {"Citation": "Greene SJ, Butler J, Spertus JA, et al. Comparison of New York Heart Association class and patient-reported outcomes for heart failure with reduced ejection fraction. JAMA Cardiol. 2021;6:522-531."}, {"Citation": "Cruz L, Ryan JJ. Nitric oxide signaling in heart failure with preserved ejection fraction. JACC Basic Transl Sci. 2017;2:341-343."}, {"Citation": "Rassaf T, Poll LW, Brouzos P, et al. Positive effects of nitric oxide on left ventricular function in humans. Eur Heart J. 2006;27:1699-1705."}, {"Citation": "Koul K, LaPenna K, Li Z, et al. Nitric oxide therapy attenuates heart failure with preserved ejection fraction. FASEBJ. 2022;36:R2429."}, {"Citation": "Chapple SJ, Cheng X, Mann GE. Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease. Redox Biol. 2013;1:319-331."}, {"Citation": "Bocci VA, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med. 2011;9:66."}, {"Citation": "de Couto G, Mesquita T, Wu X, et al. Cell therapy attenuates endothelial dysfunction in hypertensive rats with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2022;323:H892-H903."}, {"Citation": "Kelly JP, Mentz RJ, Mebazaa A, et al. Patient selection in heart failure with preserved ejection fraction clinical trials. J Am Coll Cardiol. 2015;65:1668-1682."}, {"Citation": "Mentz RJ, Kelly JP, von Lueder TG, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014;64:2281-2293."}, {"Citation": "Scantlebury DC, Borlaug BA. Why are women more likely than men to develop heart failure with preserved ejection fraction? Curr Opin Cardiol. 2011;26:562-568."}, {"Citation": "Tsch\u00f6pe C, Van Linthout S. New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2014;11:436-444."}, {"Citation": "Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385:1451-1461."}, {"Citation": "Chacko SM, Ahmed S, Selvendiran K, Kuppusamy ML, Khan M, Kuppusamy P. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol. 2010;299:C1562-1570."}, {"Citation": "Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol. 2005;46:1339-1350."}, {"Citation": "Ii M, Nishimura H, Iwakura A, et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via \"imported\" nitric oxide synthase activity. Circulation. 2005;111:1114-1120."}, {"Citation": "Kamota T, Li TS, Morikage N, et al. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol. 2009;53:1814-1822."}, {"Citation": "Kimura M, Ueda K, Goto C, et al. Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2007;27:1403-1410."}, {"Citation": "Gy\u00f6ngy\u00f6si M, Posa A, Pavo N, et al. Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion. Thromb Haemost. 2010;104:376-384."}, {"Citation": "Edwards N, Langford-Smith AWW, Wilkinson FL, Alexander MY. Endothelial progenitor cells: new targets for therapeutics for inflammatory conditions with high cardiovascular risk. Front Med (Lausanne). 2018;5:200."}, {"Citation": "Thum T, Fraccarollo D, Schultheiss M, et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes. 2007;56:666-674."}, {"Citation": "Heiss C, Wong ML, Block VI, et al. Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells. J Cell Physiol. 2008;215:366-373."}, {"Citation": "Heiss C, Schanz A, Amabile N, et al. Nitric oxide synthase expression and functional response to nitric oxide are both important modulators of circulating angiogenic cell response to angiogenic stimuli. Arterioscler Thromb Vasc Biol. 2010;30:2212-2218."}, {"Citation": "Tsirmoula S, Lamprou M, Hatziapostolou M, Kieffer N, Papadimitriou E. Pleiotrophin-induced endothelial cell migration is regulated by xanthine oxidase-mediated generation of reactive oxygen species. Microvasc Res. 2015;98:74-81."}, {"Citation": "Sharifi BG, Zeng Z, Wang L, et al. Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells. Arterioscler Thromb Vasc Biol. 2006;26:1273-1280."}]}], "History": [{"Year": "2024", "Month": "9", "Day": "1", "Hour": "16", "Minute": "17"}, {"Year": "2024", "Month": "9", "Day": "1", "Hour": "16", "Minute": "17"}, {"Year": "2023", "Month": "7", "Day": "16"}, {"Year": "2024", "Month": "7", "Day": "10"}, {"Year": "2024", "Month": "9", "Day": "1", "Hour": "2", "Minute": "22"}], "PublicationStatus": "aheadofprint", "ArticleIdList": ["39217427", "10.4103/mgr.MEDGASRES-D-23-00013", "01612956-990000000-00030"]}}], "PubmedBookArticle": []}